XML 80 R66.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders Equity and Equity Incentive Programs - Additional Information (Detail) (USD $)
9 Months Ended 1 Months Ended 9 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 1 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 1 Months Ended 3 Months Ended 9 Months Ended
Sep. 30, 2013
Dec. 31, 2012
Apr. 27, 2012
Private Placement
Sep. 30, 2013
Private Placement
Apr. 27, 2012
Private Placement
Performance Guarantee
Apr. 27, 2012
Private Placement
Capital Addition Purchase Commitments
Apr. 27, 2012
Private Placement
Research and Development Arrangement
Dec. 31, 2012
Private Placement
Embedded Derivative Financial Instruments
Sep. 30, 2013
Minimum
Private Placement
July 31, 2014 to March 31, 2015
Sep. 30, 2013
Employee Stock Option
Sep. 30, 2012
Employee Stock Option
Sep. 30, 2013
Employee Stock Option
Sep. 30, 2012
Employee Stock Option
Sep. 30, 2013
Employee Stock Purchase Plan
Sep. 30, 2012
Employee Stock Purchase Plan
Sep. 30, 2013
Employee Stock Purchase Plan
Discounted Employee Stock Purchase Plan
Sep. 30, 2013
Employee Stock Purchase Plan
Call Option
Sep. 30, 2013
Employee Stock Purchase Plan
Put Option
Sep. 30, 2013
Common Stock Warrants
Aug. 06, 2013
Performance Vested Stock Options
Jul. 11, 2013
Performance Vested Stock Options
Sep. 30, 2013
Performance Vested Stock Options
Jun. 30, 2013
Performance Vested Stock Options
Sep. 30, 2013
Performance Vested Stock Options
Sep. 30, 2013
Restricted Stock Units
Sep. 30, 2012
Restricted Stock Units
Sep. 30, 2013
Restricted Stock Units
Sep. 30, 2012
Restricted Stock Units
Aug. 06, 2013
Stock Appreciation Rights (SARs)
Jul. 11, 2013
Stock Appreciation Rights (SARs)
Sep. 30, 2013
Stock Appreciation Rights (SARs)
Jun. 30, 2013
Stock Appreciation Rights (SARs)
Sep. 30, 2013
Stock Appreciation Rights (SARs)
Class Of Stock [Line Items]                                                                  
Common stock                   6,132,549   6,132,549   594,874         4,482                            
Shares granted                   369,900 107,770 1,534,030 251,475             110,000 1,060,000                        
Weighted average exercise price                   $ 7.78 $ 5.00 $ 5.82 $ 4.90                                        
Number of days for stock price to be traded above mentioned price                                         20 days                 20 days      
Minimum closing stock price                                         $ 15.00                 $ 15.00      
Fair Value of options granted                                             $ 5.68                    
Stock options vesting period                                             7 years                 7 years  
Allocated share based compensation expense                                           $ 200,000   $ 200,000             $ 49,000   $ 62,000
Unexercised stock options outstanding 3,979,813                                                                
Shares granted                                                 606,300 428,000 637,340 615,609 25,000 250,000 25,000   275,000
Weighted average exercise price                                                 $ 6.98 $ 4.96 $ 6.98 $ 5.27 $ 4.81   $ 8.33 $ 5.41 $ 5.40
Shares outstanding                                                 1,135,929   1,135,929       433,708   433,708
Shares purchased under the ESPP                           262,860 257,335                                    
Value of shares purchased under the ESPP                           1,200,000 900,000                                    
Percentage on the stock purchase right                               15.00% 85.00% 15.00%                              
Common Stock Transfer Restriction Period     2 years                                                            
Targeted expansion completion date       Jul. 31, 2014                                                          
Extended date for achievement of Investment Obligation       Mar. 31, 2015                                                          
Expected aggregate revenue from sales of its products in the Russian Federation                 26,800,000                                                
Penalty payment derivative 238,000 138,000                                                              
Other non-current liability         30,000,000 15,000,000 15,000,000 5,000,000                                                  
Additional paid-in capital 444,552,000 438,858,000           4,900,000                                                  
Accumulated deficit subject to restriction 6,300,000                                                                
Accumulated profits 10.00%                                                                
Common Stock Issued     4,970,000                                                            
Common Stock Issue Price     $ 8.00                                                            
Proceeds from issuance of common stock, net of issuance costs     $ 39,800,000                                                            
Percentage of investment obligation that must be spent inside Russia     80.00%